Latest news
NeOnc Q2 Net Loss Widens to $14.2 Million - Quiver QuantitativeQuiver Quantitative · Mon, 10 Aug 2026 21:21:00 GMTNeOnc to present phase 2a NEO100 trial results on Tuesday - Investing.comInvesting.com · Mon, 10 Aug 2026 14:20:59 GMTNeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma - stocktwits.comstocktwits.com · Mon, 10 Aug 2026 13:42:00 GMTNEONC TECHNOLOGIES HOLDINGS, INC. Q2 2026: Revenue $0 EPS $(0.58) — 10-Q Summary - TradingViewTradingView · Mon, 10 Aug 2026 13:11:01 GMTNeOnc Technologies (NTHI) raises $20M but warns on going concern - Stock TitanStock Titan · Mon, 10 Aug 2026 13:01:37 GMTNeOnc Technologies Holdings to Host Investor Call on Phase 2a Topline Results for NEO100-01 Trial - Quiver QuantitativeQuiver Quantitative · Mon, 10 Aug 2026 12:47:00 GMTNeOnc Technologies Holdings Inc (NTHI) Stock News Today - TradingKeyTradingKey · Sat, 08 Aug 2026 02:47:11 GMTNTHI Q1 2026 Earnings: Wider-Than-Expected Loss Reflects Clinical-Stage Investment Costs - Earnings Risk Report - dars.gov.etdars.gov.et · Fri, 07 Aug 2026 23:34:23 GMT